Study of Erenumab in Adults with Chronic Migraine and Medication Overuse Headache
Study date: 23 June 2021
Status: Open
This study is currently closed to recruitment and in follow-up.
20170703 is a study in adult participants with Chronic Migraine (CM) and Medication Overuse Headache (MOH). The purpose of conducting the study is to better understand the effectiveness and safety of erenumab compared to placebo when given to a targeted population diagnosed with CM and MOH that have at least one preventative treatment failure, to see if it makes any changes in the number of days participants suffer from monthly headache days (MHD) and are able to revert the medication overuse status.